Chocolate manufacturers may have reason to celebrate even as the current US administration calls for negative interest rates. Chocolates and other confections are considered “recession proof” industries. But are... read more →
Traditionally, biopharma companies can increase their revenue for research and overhead through price increases for exclusively owned products. (First, raise the price on drugs you’ve got a patent for.... read more →
When it comes to budgeting your expenses for the next year, many operations managers start with the direct labor and material costs. That is, how much it costs to... read more →
Maybe you’re waiting out the U.S. trade war with China, or you’ve got an eye on the hard Brexit date. Or, maybe you’re just in the middle of some... read more →
The biopharma industry is one in which successful companies, investors, drug developers, and scientists can manage – even celebrate – the inevitable failures of research and development. In a... read more →